The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2008
Filed:
Aug. 11, 2004
Wayne Thompson, Landsdale, PA (US);
Steven D. Young, Lansdale, PA (US);
Brian T. Phillips, Telford, PA (US);
Peter Munson, Harleysville, PA (US);
Willie Whitter, West Point, PA (US);
Nigel Liverton, Harleysville, PA (US);
Christine Dieckhaus, North Wales, PA (US);
John Butcher, Telford, PA (US);
John A. Mccauley, Maple Glen, PA (US);
Charles J. Mcintyre, Lansdale, PA (US);
Mark E. Layton, Harleysville, PA (US);
Philip E. Sanderson, Valley Forge, PA (US);
Wayne Thompson, Landsdale, PA (US);
Steven D. Young, Lansdale, PA (US);
Brian T. Phillips, Telford, PA (US);
Peter Munson, Harleysville, PA (US);
Willie Whitter, West Point, PA (US);
Nigel Liverton, Harleysville, PA (US);
Christine Dieckhaus, North Wales, PA (US);
John Butcher, Telford, PA (US);
John A. McCauley, Maple Glen, PA (US);
Charles J. McIntyre, Lansdale, PA (US);
Mark E. Layton, Harleysville, PA (US);
Philip E. Sanderson, Valley Forge, PA (US);
Merck & Co., Inc., Rahway, NJ (US);
Abstract
Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.